1
|
Lung cancer statistics. Cancer research
UK, Oxford, 2018. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer.
Accessed April 4, 2018.
|
2
|
Bannister N and Broggio J: Survival for
people diagnosed by cancer type, split by stage at diagnosis. Data
based on people diagnosed in England in. 2012, 2013 and 2014.
Produced in collaboration with Public Health England (PHE). In:
Cancer survival by stage at diagnosis for England (experimental
statistics): Adults diagnosed 2012, 2013 and 2014 and followed up
to 2015. Office for National Statistics, Newport, pp1-30, 2016.
|
3
|
National Lung Screening Trial Research
Team. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom
RM, Gareen IF, Gatsonis C, Marcus PM and Sicks JD: Reduced lung
cancer mortality with low dose computed tomographic screening. N
Engl J Med. 365:395–409. 2011.PubMed/NCBI View Article : Google Scholar
|
4
|
Pantel K, Brakenhoff RH and Brandt B:
Detection, clinical relevance and specific biological properties of
disseminating tumour cells. Nat Rev Cancer. 8:329–340.
2008.PubMed/NCBI View
Article : Google Scholar
|
5
|
Zhang Z, Ramnath N and Nagrath S: Current
Status of CTCs as Liquid Biopsy in Lung Cancer and Future
Directions. Front Oncol. 5(209)2015.PubMed/NCBI View Article : Google Scholar
|
6
|
Hou HW, Warkiani ME, Khoo BL, Li ZR, Soo
RA, Tan DS Lim WT, Han J, Bhagat AA and Lim CT: Isolation and
retrieval of circulating tumor cells using centrifugal forces. Sci
Rep. 3(1259)2013.PubMed/NCBI View Article : Google Scholar
|
7
|
Dent BM, Ogle LF, O'Donnell RL, Hayes N,
Malik U, Curtin NJ, Boddy AV, Plummer ER, Edmondson RJ, Reeves HL,
et al: High-resolution imaging for the detection and
characterisation of circulating tumour cells from patients with
oesophageal, hepatocellular, thyroid and ovarian cancers. Int J
Cancer. 138:206–216. 2016.PubMed/NCBI View Article : Google Scholar
|
8
|
Chudasama D, Barr J, Beeson J, Beddow E,
McGonigle N, Rice A, Nicholson A and Anikin V: Detection of
Circulating Tumour Cells and Survival of Patients with Non-small
Cell Lung Cancer. Anticancer Res. 37:169–173. 2017.PubMed/NCBI View Article : Google Scholar
|
9
|
Chudasama D, Rice A, Anikin V, Soppa G and
Dalal P: Circulating Tumour Cells in Patients with Malignant Lung
Tumors Undergoing Radio-frequency Ablation. Anticancer Res.
35:2823–2826. 2015.PubMed/NCBI
|
10
|
Chudasama D, Burnside N, Beeson J,
Karteris E, Rice A and Anikin V: Perioperative detection of
circulating tumour cells in patients with lung cancer. Oncol Lett.
14:1281–1286. 2017.PubMed/NCBI View Article : Google Scholar
|
11
|
Chudasama D, Rice A, Soppa G and Anikin V:
Circulating tumour cells in patients with lung cancer undergoing
endobronchial cryotherapy. Cryobiology. 71:161–163. 2015.PubMed/NCBI View Article : Google Scholar
|
12
|
Freidin MB, Tay A, Freydina DV, Chudasama
D, Nicholson AG, Rice A, Anikin V and Lim E: An assessment of
diagnostic performance of a filter-based antibody-independent
peripheral blood circulating tumour cell capture paired with
cytomorphologic criteria for the diagnosis of cancer. Lung Cancer.
85:182–185. 2014.PubMed/NCBI View Article : Google Scholar
|
13
|
Popper HH: Progression and metastasis of
lung cancer. Cancer Metastasis Rev. 35:75–91. 2016.PubMed/NCBI View Article : Google Scholar
|
14
|
Chen FF, Zhang D, Wang YL and Xiong B:
Video-assisted thoracoscopic surgery lobectomy versus open
lobectomy in patients with clinical stage Ⅰ non-small cell lung
cancer: A meta-analysis. Eur J Surg Oncol. 39:957–963.
2013.PubMed/NCBI View Article : Google Scholar
|
15
|
Cai YX, Fu XN, Xu QZ, Sun W and Zhang N:
Thoracoscopic lobectomy versus open lobectomy in stage I non-small
cell lung cancer: A meta-analysis. PLoS One.
8(e82366)2013.PubMed/NCBI View Article : Google Scholar
|